Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02837276 · ClinicalTrials.gov registry record
Intermittent Hypoxemia and Acute Kidney Injury Study (IHAKI Study)
A clinical trial of Acute Kidney Injury and Preterm Infant, sponsored by Elie G. Abu Jawdeh, MD.
- Completed
- Registry status
- 41
- Enrollment target
- 1
- Study location
NCT02837276 is a study of Acute Kidney Injury and Preterm Infant that has completed, run by Elie G. Abu Jawdeh, MD. The registered enrollment target is 41 participants, below the 2,330-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02837276, a study of Acute Kidney Injury and Preterm Infant, has completed, sponsored by Elie G. Abu Jawdeh, MD.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot study aims at investigating the relationship between intermittent hypoxemia (IH) and acute kidney injury (AKI) in preterm infants. AIM 1: Test the hypothesis that intermittent hypoxemia is associated kidney injury in preterm infants, as reflected by a rise in serum creatinine. AIM 2: Test the hypothesis that there is rise in acute kidney injury urinary biomarkers with increased intermittent hypoxemia.
Conditions Studied
Study Locations (1)
Kentucky
- University of Kentucky - Kentucky Children's Hospital - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2016-07 |
| Est. Completion | 2018-01-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02837276
The ClinicalTrials.gov registry entry for NCT02837276 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,330-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (98% lower). The listed sponsor is Elie G. Abu Jawdeh, MD, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Acute Kidney Injury appearing as the primary indexed condition, and to 0 interventions.
NCT02837276 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT02837276 about?
NCT02837276 is a clinical study titled "Intermittent Hypoxemia and Acute Kidney Injury Study (IHAKI Study)". This pilot study aims at investigating the relationship between intermittent hypoxemia (IH) and acute kidney injury (AKI) in preterm infants. AIM 1: Test the hypothesis that intermittent hypoxemia is associated kidney injury in preterm infants, as reflected by a rise in serum creatinine. AIM 2: Te...
What is the current status of trial NCT02837276?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2016-07. Estimated completion is 2018-01-15.
What conditions does trial NCT02837276 study?
This clinical trial studies the following conditions: Acute Kidney Injury, Preterm Infant, Intermittent Hypoxemia.
Who is sponsoring clinical trial NCT02837276?
This trial is sponsored by Elie G. Abu Jawdeh, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02837276 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Kidney Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ultra-Low Contrast Angiography in AKI
RECRUITING · Phase 3
-
Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy
RECRUITING
-
Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry
RECRUITING
-
Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury
RECRUITING · Phase 2
-
Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage
RECRUITING · Phase 1
-
Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.